Inactivation of multidrug resistant (MDR)- and extensively drug resistant (XDR)-Mycobacterium tuberculosis by photodynamic therapy

Photodiagnosis and Photodynamic Therapy

Volumn 10, Issue 4, 2013, Pages 694-702

  Sung, Nackmoon ^a   Back, Sunmi ^a   Jung, JinHee ^a   Kim, Ki Hong ^b   Kim, Jong Ki ^b   Lee, Jae Ho ^c,d   Ra, Yongjoon ^c   Yang, Hee Chul ^c   Lim, Cheong ^c,d   Cho, Sukki ^c,d   Kim, Kwhanmien ^c,d   Jheon, Sanghoon ^c,d  

^a National Masan Tuberculosis Hospital   (South Korea)

^b Catholic University of Daegu   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

D value; MDR TB; PDT; XDR TB

Indexed keywords

DHI 1803; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLI; BACTERIAL STRAIN; COLONY FORMING UNIT; CONTROLLED STUDY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; HUMAN; IN VITRO STUDY; IRRADIATION; LASER; LIGHT EXPOSURE; LINEAR REGRESSION ANALYSIS; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

BACILLI (CLASS); MYCOBACTERIUM TUBERCULOSIS;

D-VALUE; MDR-TB; PDT; XDR-TB;

APOPTOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; MYCOBACTERIUM TUBERCULOSIS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; TREATMENT OUTCOME;

EID: 84888064649     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2013.09.001     Document Type: Article

References (49)

1. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004. Morb Mortal Wkly Rep 2006, 55:301-305.
2. Ackroyd R., Kelty C., Brown N., Reed M. The history of photodetection and photodynamic therapy. Photochem Photobiol 2001, 74:656-669.
3. Anek-Vorapong R., Sinthuwattanawibool C., Podewils L.J., McCarthy K., Ngamlert K., Promsarin B., et al. Validation of the GenoType MTBDRplus assay for detection of MDR-TB in a public health laboratory in Thailand. BMC Infect Dis 2010, 10:123.
4. Bai G.H., Park Y.K., Choi Y.W., Bai J.I., Kim H.J., Chang C.L., et al. Trend of anti-tuberculosis drug resistance in Korea, 1994-2004. Int J Tuberc Lung Dis 2007, 11:571-576.
5. Brennan P.J. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis 2003, 83:91-97.
6. Brennan P.J., Nikaido H. The envelope of mycobacteria. Annu Rev Biochem 1995, 64:29-63.
7. Castano A.P., Mroz P., Hamblin M.R. Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 2006, 6:535-545.
8. Castano A.P., Mroz P., Wu M.X., Hamblin M.R. Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model. Proc Natl Acad Sci U S A 2008, 105:5495-5500.
9. Chatterjee S., Price B. Regression Analysis by Example 1991, 107-116. John Wiley & Sons, New York. 2 ed.
10. Comas I., Gagneux S. The past and future of tuberculosis research. PLoS Pathog 2009, 5:e1000600.
11. Douillard S., Lhommeau I., Olivier D., Patrice T. In vitro evaluation of Radachlorin sensitizer for photodynamic therapy. J Photochem Photobiol B 2010, 98:128-137.
12. Douillard S., Olivier D., Patrice T. In vitro and in vivo evaluation of Radachlorin(R) sensitizer for photodynamic therapy. Photochem Photobiol Sci 2009, 8:405-413.
13. Draper N.R., Smith H. Applied Regression Analysis 1981, 241-257. John Wiley & Sons, New York. 2 ed.
14. Grant I.R., Ball H.J., Neill S.D., Rowe M.T. Inactivation of Mycobacterium paratuberculosis in cows' milk at pasteurization temperatures. Appl Env Microbiol 1996, 62:631-636.
15. Grinholc M., Szramka B., Olender K., Graczyk A. Bactericidal effect of photodynamic therapy against methicillin-resistant Staphylococcus aureus strain with the use of various porphyrin photosensitizers. Acta Biochim Pol 2007, 54:665-670.
16. Hamblin M.R., Hasan T. Photodynamic therapy: a new antimicrobial approach to infectious disease?. Photochem Photobiol Sci 2004, 3:436-450.
17. Hillemann D., Rusch-Gerdes S., Richter E. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2007, 45:2635-2640.
18. Hwang S.S., Kim H.R., Kim H.J., Kim M.J., Lee S.M., Yoo C.G., et al. Impact of resistance to first-line and injectable drugs on treatment outcomes in MDR-TB. Eur Respir J 2009, 33:581-585.
19. Johnston J.C., Shahidi N.C., Sadatsafavi M., Fitzgerald J.M. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS ONE 2009, 4:e6914.
20. Jori G. Photodynamic therapy of microbial infections: state of the art and perspectives. J Environ Pathol Toxicol Oncol 2006, 25:505-519.
21. Jori G., Fabris C., Soncin M., Ferro S., Coppellotti O., Dei D., et al. Photodynamic therapy in the treatment of microbial infections: basic principles and perspective applications. Lasers Surg Med 2006, 38:468-481.
22. Jurczak A., Szramka B., Grinholc M., Legendziewicz J., Bielawski K.P. Photodynamic effect of lanthanide derivatives of meso-tetra(N-methyl-4-pyridyl)porphine against Staphylococcus aureus. Acta Biochim Pol 2008, 55:581-585.
23. Kaplan G., Post F.A., Moreira A.L., Wainwright H., Kreiswirth B.N., Tanverdi M., et al. Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity. Infect Immun 2003, 71:7099-7108.
24. Lacoma A., Garcia-Sierra N., Prat C., Ruiz-Manzano J., Haba L., Roses S., et al. GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples. J Clin Microbiol 2008, 46:3660-3667.
25. Laserson K.F., Thorpe L.E., Leimane V., Weyer K., Mitnick C.D., Riekstina V., et al. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2005, 9:640-645.
26. Lim D.-S., Ko S.-H., Won D.-H., Lee S.-H., Lee W.-Y. Photodynamic andti-tumor activity of a new chlorin-based photosensitizer against Lewis Lung Carninoma cells in vitro and in vivo. J Porphyrin Phthalocyan 2003, 7:155-161.
27. Mah N., Perez-Iratxeta C., Andrade-Navarro M.A. Outer membrane pore protein prediction in mycobacteria using genomic comparison. Microbiology 2010, 156:2506-2515.
28. Maisch T. A new strategy to destroy antibiotic resistant microorganisms: antimicrobial photodynamic treatment. Mini Rev Med Chem 2009, 9:974-983.
29. Moats W.A. Kinetics of thermal death of bacteria. J Bacteriol 1971, 105:165-171.
30. Momma T., Hamblin M.R., Wu H.C., Hasan T. Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis. Cancer Res 1998, 58:5425-5431.
31. Mroz P., Pawlak A., Satti M., Lee H., Wharton T., Gali H., et al. Functionalized fullerenes mediate photodynamic killing of cancer cells: type I versus type II photochemical mechanism. Free Radic Biol Med 2007, 43:711-719.
32. O'Riordan K., Akilov O.E., Chang S.K., Foley J.W., Hasan T. Real-time fluorescence monitoring of phenothiazinium photosensitizers and their anti-mycobacterial photodynamic activity against Mycobacterium bovis BCG in in vitro and in vivo models of localized infection. Photochem Photobiol Sci 2007, 6:1117-1123.
33. O'Riordan K., Sharlin D.S., Gross J., Chang S., Errabelli D., Akilov O.E., et al. Photoinactivation of Mycobacteria in vitro and in a new murine model of localized Mycobacterium bovis BCG-induced granulomatous infection. Antimicrob Agents Chemother 2006, 50:1828-1834.
34. Onyebujoh P., Zumla A., Ribeiro I., Rustomjee R., Mwaba P., Gomes M., et al. Treatment of tuberculosis: present status and future prospects. Bull World Health Organ 2005, 83:857-865.
35. Raab O. Uber die Wirkung fluoreszierender Stoffe auf Infusorien. Z Biol 1900, 39:524-546.
36. Shih M.H., Huang F.C. Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis. Invest Ophthalmol Vis Sci 2011, 52:223-229.
37. Siroy A., Mailaender C., Harder D., Koerber S., Wolschendorf F., Danilchanka O., et al. Rv1698 of Mycobacterium tuberculosis represents a new class of channel-forming outer membrane proteins. J Biol Chem 2008, 283:17827-17837.
38. Sung N., Collins M.T. Thermal tolerance of Mycobacterium paratuberculosis. Appl Env Microbiol 1998, 64:999-1005.
39. Sung N., Collins M.T. Effect of three factors in cheese production (pH, salt, and heat) on Mycobacterium avium subsp. paratuberculosis viability. Appl Environ Microbiol 2000, 66:1334-1339.
40. Sung N., Takayama K., Collins M.T. Possible association of GroES and Antigen 85 proteins with heat resistance of Mycobacterium paratuberculosis. Appl Env Microbiol 2004, 70:1688-1697.
41. Taylor P.W., Stapleton P.D., Paul L.J. New ways to treat bacterial infections. Drug Discov Today 2002, 7:1086-1091.
42. Visser M.E., Stead M.C., Walzl G., Warren R., Schomaker M., Grewal H.M., et al. Baseline predictors of sputum culture conversion in pulmonary tuberculosis: importance of cavities, smoking, time to detection and W-Beijing genotype. PLoS ONE 2012, 7:e29588.
43. Wainwright M. Photodynamic antimicrobial chemotherapy (PACT). J Antimicrob Chemother 1998, 42:13-28.
44. Wiegell S.R., Kongshoj B., Wulf H.C. Mycobacterium marinum infection cured by photodynamic therapy. Arch Dermatol 2006, 142:1241-1242.
45. Wong T.W., Wang Y.Y., Sheu H.M., Chuang Y.C. Bactericidal effects of toluidine blue-mediated photodynamic action on Vibrio vulnificus. Antimicrob Agents Chemother 2005, 49:895-902.
46. Goidelines for the programmatic management od drug-resistant tuberculosis emergency update 2008 2008, World Health Organization, World Health Organization, Geneva.
47. Yoder M., Lamichhane G., Bishai W.R. Cavitary pulmonary tuberculosis: The Holy Grail of disease transmission. Curr Sci 2004, 86:74-81.
48. Zhang L., Ye Y., Duo L., Wang T., Song X., Lu X., et al. Application of genotype MTBDRplus in rapid detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin in a high volum laboratory in Southern China. Mol Biol Rep 2010.
49. Zolfaghari P.S., Packer S., Singer M., Nair S.P., Bennett J., Street C., et al. In vivo killing of Staphylococcus aureus using a light-activated antimicrobial agent. BMC Microbiol 2009, 9:27.